Investigating Neurocognitive Disorders Epidemiology - Trial NCT06375213
Access comprehensive clinical trial information for NCT06375213 through Pure Global AI's free database. This phase not specified trial is sponsored by King Chulalongkorn Memorial Hospital and is currently Recruiting. The study focuses on Dementia,Cognitive Decline,Alzheimer Disease. Target enrollment is 990 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Plasma tau phosphorylated at Thr217
Observational
diagnostic test
Sponsor & Location
King Chulalongkorn Memorial Hospital
Timeline & Enrollment
N/A
Aug 24, 2023
Aug 24, 2035
Primary Outcome
Progression to dementia,Changes in Sum of Boxes of the Clinical Dementia Rating Scale
Summary
This is a prospective cohort study with the main purpose of predicting progression
 neurocognitive disorders in Thai population. The main predictor variables to be evaluated are
 plasma phosphorylated tau (p-tau) level and cognitive test scores, which will be combined
 using statistical/computational modeling. Additionally, it seeks to evaluate biomarkers for
 diagnosing disease pathologies, understand their correlation with clinical outcomes, and
 explore the socioeconomic impact of neurocognitive disorders. The study invites both
 participants for biospecimen collection, structured interviews, and cognitive examinations
 and schedules follow-up visits annually or biennially.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06375213
Non-Device Trial